How to Apply:
The specific objectives of this funding opportunity are:
- To generate knowledge regarding the heterogeneity of type 1 diabetes (T1D) that will enable and inform new precision medicine approaches for the prediction, prevention, care or treatment of T1D; and
- To advance curative and disease-modifying therapies for T1D using precision medicine approaches.
Thursday, July 21, 2022